Susquehanna Portfolio Strategies’s Amneal Pharmaceuticals AMRX Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.08M	Hold	328,003	–	–	0.06%	336
2025 Q4	$4.13M	Hold	328,003	–	–	0.06%	338
2025 Q3	$3.28M	Buy	328,003 +82,808	+34%	+$743K	0.05%	392
2025 Q2	$1.98M	Buy	245,195 +206,674	+537%	+$1.56M	0.04%	375
2025 Q1	$323K	Buy	+38,521	New	+$322K	0.14%	96
2024 Q2	–	Sell	-64,584	Closed	-$391K	–	515
2024 Q1	$391K	Sell	64,584 -3,247	-5%	-$18.3K	0.01%	627
2023 Q4	$412K	Buy	+67,831	New	+$302K	0.01%	802

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Susquehanna Portfolio Strategies's AMRX Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 328,003 shares worth $4.08M. The position accounts for 0.06% of the portfolio, ranked #336.

Susquehanna Portfolio Strategies first reported a position in AMRX in Q4 2023 and has held it in 7 quarters since. The position peaked at $4.13M in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Susquehanna Portfolio Strategies held 328,003 shares of Amneal Pharmaceuticals worth $4.08M as of Q1 2026.
Susquehanna Portfolio Strategies left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
Amneal Pharmaceuticals made up 0.06% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #336 holding.
Susquehanna Portfolio Strategies first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
Susquehanna Portfolio Strategies's Amneal Pharmaceuticals position peaked at $4.13M in Q4 2025.
315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.